Correlation Between Intellia Therapeutics and Allogene Therapeutics
Can any of the company-specific risk be diversified away by investing in both Intellia Therapeutics and Allogene Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intellia Therapeutics and Allogene Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Intellia Therapeutics and Allogene Therapeutics, you can compare the effects of market volatilities on Intellia Therapeutics and Allogene Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intellia Therapeutics with a short position of Allogene Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intellia Therapeutics and Allogene Therapeutics.
Diversification Opportunities for Intellia Therapeutics and Allogene Therapeutics
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Intellia and Allogene is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Intellia Therapeutics and Allogene Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allogene Therapeutics and Intellia Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intellia Therapeutics are associated (or correlated) with Allogene Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allogene Therapeutics has no effect on the direction of Intellia Therapeutics i.e., Intellia Therapeutics and Allogene Therapeutics go up and down completely randomly.
Pair Corralation between Intellia Therapeutics and Allogene Therapeutics
Given the investment horizon of 90 days Intellia Therapeutics is expected to under-perform the Allogene Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Intellia Therapeutics is 1.27 times less risky than Allogene Therapeutics. The stock trades about -0.05 of its potential returns per unit of risk. The Allogene Therapeutics is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest 562.00 in Allogene Therapeutics on November 1, 2024 and sell it today you would lose (370.00) from holding Allogene Therapeutics or give up 65.84% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Intellia Therapeutics vs. Allogene Therapeutics
Performance |
| Timeline |
| Intellia Therapeutics |
| Allogene Therapeutics |
Intellia Therapeutics and Allogene Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Intellia Therapeutics and Allogene Therapeutics
The main advantage of trading using opposite Intellia Therapeutics and Allogene Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intellia Therapeutics position performs unexpectedly, Allogene Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allogene Therapeutics will offset losses from the drop in Allogene Therapeutics' long position.| Intellia Therapeutics vs. Editas Medicine | Intellia Therapeutics vs. Caribou Biosciences | Intellia Therapeutics vs. Crispr Therapeutics AG | Intellia Therapeutics vs. Verve Therapeutics |
| Allogene Therapeutics vs. Heron Therapeuti | Allogene Therapeutics vs. Annexon | Allogene Therapeutics vs. Sangamo Therapeutics | Allogene Therapeutics vs. Beam Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |